Microalbuminuria in hypertension

Nephron

Volumn 73, Issue 4, 1996, Pages 499-505

  Pedrinelli, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ANIMAL; EDITORIAL; HUMAN; HYPERTENSION; URINE;

ALBUMINURIA; ANIMALS; HUMANS; HYPERTENSION;

EID: 0030346125     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189131     Document Type: Article

References (103)

1. Parving HH. Mogcnscn CH. Jensen HE. Evrin PE: Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974: i: 1190-1192.
2. Vibcrti GC. Hill RD. Jarret RJ. Argyropoulos A. Mahmud U. Keen M: Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus. Lancet 1982;i: 1430-1432.
3. Mathicsen ER, Ronn B, Jensen T, Storm B, Decken T: Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes I990;39: 245-249.
4. Hansen KW. Christensen CK. Anderson PH. Christiansen JS. Mogensen CE: Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 1992:41:847-854.
5. Kilaru P. Bakris GL: Microalbuminuria and progressive renal disease. J Hum Hvperlens 1994;8:809-817.
6. Dimmitt SB. Lindquist TL. Mamotte CDS. Burke V, Beilin LJ: Urine albumin excretion in healthy subjects. J Hum Hypertens 1993;7: 239-243.
7. Nelson RG. Kunzelman CL. Pettitt DJ. Saad MF. Bennett PH. Knowler WC: Albuminuria in type 2 (non insulin dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabctologia 1989:32:870-876.
8. Winocour PH. Harland JOE, Millar JP. Laker MF. Alberti KGMM: Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992:93:71-81.
9. Woo J, Cockram CS. Swaminathan R. Lau E, Chan A. Cheung R: Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects. Int J Cardiol 1992:37:345-350.
10. Gould MM. Mohamed-Ali V. Goubert SA. Yudkni JS. Haines AP: Microalbuminuria: Associations with height and sex in nondiabetic subjects. BMJ 1993:306:240-242.
11. Yudkin JS. Forrest RD. Jackson CA: Microalbuminuria as a predictor of vascular disease in nondiabetic subjects. Lancet 1988;ii:530-534.
12. Haffner SM, Stern MP, Kozlowski Gruber MK, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria, Potential marker for increased cardiovascular risk factors in nondiabetic subjects, Arteriosclerosis 1990; 10:727-731.
13. Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW: Prevalence and risk factors for micro-and macroalbuminuria in diabetic subjects and entire population of Nauru, Diabetes 1989:38:1602-1610.
14. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM, Diabetes 1994;43: 552-557.
15. Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, Monterrosa A, Stem MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study, Diabetologia 1993;36:1002-1006.
16. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people, Br Med J 1990:300:297-300.
17. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E: Albuminuria in people at least 40 year old: Effect of obesity, hypertension and hypcrlipidemia, Clin Client 1992:38:1802-1808.
18. Pontremoli R, Cheli V, Sofia A, Tirotta A, Ra-vera M, Nicolella C, Ruello N, Tomolillo C, Antonucci GC, Bessarione D, De Ferrari G: Prevalence of micro-and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension, Nephrol Dial Transplant 1995:10(s6):6-9.
19. Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J: Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normoten-sion, Hypertension 1994:24:101-105.
20. Redon J, Liao Y, Lozano JV, Miralles A, Pas-cual JM, Cooper RS: Ambulatory blood pressure and microalbuminuria in essential hypertension: Role of circadian variability, J Hypertens 1994;12:947-953.
21. Agewall S, Persson B, Samuelsson O, Ljung-man S, Herlitz H, Fagcrbcrg B: Microalbuminuria in treated hypertensive men at high risk of coronary disease, J Hypertens 1993; 11:461-469.
22. Mimran A, Ribstein J, Du Cailar G, Halimi JM: Albuminuria in normals and essential hypertension, J Diabetes Complications 1994:8: 150-156.
23. Bigazzi R, Bianchi S, Campese V, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension, Nephron 1992:61:94-97.
24. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapele E, Nardi E, Andronico G, Fulantelli MA, Marcellino T, Seddio G: Microalbuminuria as a predictor of cardiovascular damage in essential hypertension, J Hypertens 1989;7(s6):s332-s333.
25. Gosling P, Bcvcrs DG: Urinary albumin excretion and blood pressure in the general population, Clin Sci 1989;76:39-42.
26. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension, Am J Hvpertens 1989:2: 259-261.
27. Dimmitt SB, Eames SM, Gosling P, West JNW, Gibson JM, Litller WA: Usefulness of ophthalmoscopy in mild to moderate hypertension, Lancet 1989;i:1103-1106.
28. Gilbert RE, Phillips P, Jerums G: Relationship between ambulatory blood pressure and albuminuria in normal subjects, Am J Hypertens 1991;4:959-962.
29. De Blok K, Veerman DP, Hock F, De Koning H, Van Montfrans GA: Relationship between blood pressure, as measured by a nurse, by a doctor and under basal conditions, and microalbuminuria and left ventricular mass, J Hypertens 1991;8(s6):s106-s107.
30. West JNW, Gosling P, Dimmitt SB, Littler WA: Non diabetic microaluminuria in clinical practice and its relationship to posture, exercise and blood pressure, Clin Sci 1991:81:373-377.
31. Ccsarola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Andronico G, Contorno A, Nardi E: Microalbuminuria points out early renal and cardiovascular changes in essential hypertension, Rev Lat Cardiol 1992;13:3-7.
32. Gerber LM, SmuklerC, Alderman MH: Differences in urinar albumin excretion rate between normotensive and hypertensive, white and non white subjects, Arch Int Med 1992; 152:373-377.
33. Pedrinelli R, DiBello VA, Catapano G, Talari-co L, Matcrazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M: Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients, Arteriosclerosis 1993:13:900-906.
34. Jantes MA, Fotherbv MD, Potter JF: Microalbuminuria in elderly hypertensives: Reproducibility and relation to clinic and ambulator’ blood pressure, J Hypertens 1994;12:309-314.
35. Pedrinelli R, Catapano G, Dell'Omo G, Mclillo E, Talarico L, Di Muro C, Giampietro O, Carmassi F, Giusti C, Di Bello VA: Forearm reserve and the cardiac and renal indices of pressure load in normo-and hypertensives, Hypertension 1994:24:24-29.
36. Pedrinelli R, Giampietro O, Cannassi O, Melillo E, Del'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V: Microalbuminuria and endothelial dysfunction inessential hypertension, Lancet 1994:344:14-18.
37. Giampietro O, Matteucci E, Catapano G, DelPOmo G, Talarico L, Di Muro C, Di Bello V, Pedrinelli R: Microalbuminuria and erythrocyte sodium/hydrogen exchange in essential hypertension, Hypertension, 1995:25:981-985.
38. Falkner B, Kushner II, Levison S, Canessa M: Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension, Hypertension 1995:25:1315-1321.
39. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese V: Diurnal variations of blood pressure and microalbuminuria in essential hypertension, Am J Hypertens 1994;7:23-29.
40. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE: Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension, Clin Sci 1990;79:5-8.
41. Christensen CK: Rapidly reversible albumin and betai-microglobulin hypercxcretion in recent severe essential hypertension, J Hypertens 1983;1:45-51.
42. Pedersen EB, Mogensen CE: Effect of antihy-pertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension, Scand J Clin Lab Invest 1976:36:231-237.
43. Yamada T, Ishihara M, Ichikawa K, Hiramat-su K: Proteinuria and renal function during antihypertensive treatment for essential hypertension, J Am Geriatr Soc 1980;28:114-117.
44. Bianchi S, Bigazzi R, Baldari G, Campese VM: Microalbuminuria in patients with essential hypertension, Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker, Am J Hvpcrtens 1991:4:291-296.
45. Persson B, Andcrsson OK, Wysocki M, Hedner T, Karlebcrg B: Calcium antagonism in essential hypertension: Effect on renal hacmody-namics and microalbuminuria, J Intern Med 1992:251:48-52.
46. Erley CM, Haefcle U, Heyne N, Braun N, Ris-lerT: Microalbuminuria in essential hypertension, Reduction by antihypertensive drugs, Hypertension 1993;21:810-815.
47. Abraham PA, Mascioli SR, Launer CA, Flack JM, Liebson PR, Svcndsen KH, Grandits GA, Opsahl JA, Shoenberger JA, Grimm RH: Urinary albumin and N-aeetyl-ß-D-glucosamini-dase excretions in mild hypertension, Am J Hypertens 1994;7:965-974
48. Berrut G, Chameau AM, Bouhanick B, Page JD, Hallab M, Richard C, Giraull A, Fresinaud P, MarreM: Microalbuminuricet hypertrophic ventriculaire gauche au cours de l'hypertension artérielle essentielle, Presse Mcd 1992:21: 1275-1278.
49. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS: Factors related to the presence of microalbuminuria in essential hypertension, Am J Hypertens 1994;7:801-807.
50. Folkow B: The structural factor’ in hypertension: With special emphasis on the hypertrophic adaption of the systemic resistance vessels; in Laragli JH, Brenner BM (eds); Hypertension: Pathophysiology, Diagnosis and Management, New York, Raven Press, 1990, chap 37, pp 547-564.
51. Bigazzi R, Bianchi S, Baldari D, Sghcrri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients, A marker for renal and cardiovascular risk factors, Hypertension 1994;23:195-199.
52. Moorhead JF, El-Nahas M, Chan MK, Varghcse Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease, Lancet, 1982;ii: 1310-1311.
53. Kasiske BL, O'Donncl MP, Cowardin W, Keane WF: Lipids and the kidney, Kidney Int 1990:15:443-450.
54. Smellie WSA, Warwick GL: Primary’ hyperlip-idcmia is not associated with increased urinary albumin excretion, Nephrol Dial Transplant 1991;6:398-401.
55. Shoji T, Nishizawa A, Kawagishi T, Okuno Y, Moori H: Decreased albuminuria by pravastatin in hyperlipidémie diabetics, Nephron 1991; 59:664-665.
56. Hommel E, Andersen P, Gall MA, Nielsen F, Jensen B, Rossing P, Dyerberg J, Parving HH: Plasma lipoproteins and renal function during sinvastatin treatment in diabetic nephropathy, Diabctologia 1992:35:447-451.
57. Niskanen L, Uusitupa M, Sarlund H, Sutonen O, Voutilainen E, Pentila L, Pyorala K: Microalbuminuria predicts the development of scrum lipoprotein abnormalities in newly diagnosed type 2 (noninsulin-depcndcnt) diabetic patients, Diabctologia 1990:33:237-243.
58. Reaven GM: Role of insulin resistance in human disease, Diabetes 1988;37:1595-1607.
59. Fcrranini E, Buzzigoli G, Bonadonna R, Giori-co MA, Oleggini M, Graziadci L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension, N Engl J Med 1987: 317:350-357.
60. Yip J, Mattock MB, Morocult A, Sethi M, Tre-visan R, Viberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria, Lancet 1993:342:883-887.
61. Niskanen L, Laakso M: Insulin resistance is related to microalbuminuria in patients with type II (non-insulin-depcndent) diabetes melli-tus, Metabolism 1993:42:1541-1545.
62. Groop L, Ekstrand A, Forsblom C, Widen E, Groop PH, Teppo AM, Eriksson J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insuiin-dcpcn-dcnt) diabetes mellitus, Diabctologia 1993:36: 642-647.
63. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari CL Natali A, Ferrannini E, Campese VM: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria, Hypertension 1994;23(p1): 681-687.
64. Agewall S, Fagerberg B, Attval S, Ljungman S, Urbanavicius V, Tengbom L, Wikstrand J: Microalbuminuria, insulin sensitivity and hemostatic factors in nondiabctic treated hypertensive men.,.,! Intern Med 1995:237:195-203.
65. Mahnensmith RL, Aronson PS: The plasma membrane sodiunt-hydrogen exchanger and its role in physiological and pathophysiological processes, C'ire Res 1985:56:773-778.
66. Doria A, Fioretto P, Avogaro A, Carraro A, Morocutti A, Trevisan R, brigato F, Crepaldi G, Viberti G, Nosadini R: Insulin resistance is associated with high sodium-lithium counter-transport in essential hypertension, Am J Physiol 1991:261:E684-H691.
67. Nosadini R, Semplicini A, Fioretto P, Lusioani T, Trevisan R, Donadon V, Nicolosi GL, Dall'Aglio V, Zanuttini D, Viberti GC: Sodi-um-lithium countertransport and cardiorenai abnormalities in essential hypertension, Hypertension 1991:18:191-198.
68. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: Hyperinsulinémie microalbuminuria, A new risk indicator for coronary heart disease, Circulation 1995:91:831-837.
69. Gosling P, Shearman C, Beevers DG: Urinary albumin excretion in smokers and nonsmokers, Contrib Nephrol 1990:83:151-155.
70. Metcalf PA, Baker JR, Scragg RKR, Dryson E, Scott AJ, Wild CJ: Albuminuria in people at least 40 years old: Effect of alcohol consumption, regular exercise and cigarette smoking, ClinChem 1993:39:1793-1797.
71. Chase PH, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamntan RE: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes, JAMA 1991;265:614-617.
72. Corradi L, Zoppi A, Tcttamanti F, Malamani G, Lazzari P, Fogari R: Association between smoking and microalbuminuria in hypertensive patients with type 2 diabetes mellitus, J Hypertens 1993:11 (s5):s190-s191.
73. Jemsen HW, Andersen B, Nielsen SL, Christensen NJ: Long term smoking increases transcapillary escape rate of albumin, Scand J Clin Lab Invest 1992;52:653-656.
74. Criqüi MH, Cowan LD, Hciss G, Haskell WL, Laskarzewski PM, Chambless LE: Frequency and distribution of nonlipid coronary risk factors in dyslipoprotcincmia, Circulation 1986: 73(s1):I-40-I-50.
75. Mancia G, Groppclli A, Casadei R, Omboni S, Mutti H, Paratti G: Cardiovascular effects of smoking, Clin Exp Hvpertens 1990; 12:917-929.
76. Facchini FS, Hollcmbeck CB, Jeppescn J, Chen YDI, Rcaven GM: Insulin resistance and cigarette smoking, Lancet 1992:339:1128-1130.
77. Grunfcld B, Pereistein E, Simsolo R, Gimenez M, Romero JC: Renal functional reserve and microalbuminuria in offspring of hypertensive parents, Hypertension 1990;15:257-261
78. Fauvel JP, Hadj-Aissa A, Laville M, Fadat G, Labeeuw M, Zcch P, Pozct N: Microalbuminuria in normotensives with genetic risk of hypertension, Nephron 1991:57:375-376.
79. Frcirc MBS, Ferreira SRG, Vivolo MA, Oliveira JM, Zanella MT: Familial hypertension and albuminuria in normotensive type I diabetic patients, Hypertension 1994;23(s1):I-256-I-258.
80. Losito A, Fortunati F, Zampi I, Del Favero A: Impaired functional reserve and albuminuria in essential hypertension, Bi Med J 1988;296: 1562-1564, ‘
81. Mimran A, Ribstein J, DuCailar G: Is microalbuminuria a marker of early intrarenal vascular dysfunction? Hypertension 1994:23(p2): 1018-1021.
82. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention trial, JAMA 1992;268:3085-3091.
83. Maki DD, Ma JZ, Louis TA, Kasiskc BL: L., ong-lerm effects of antihypertensive agents on proteinuria and renal function, Arch Intern Med 1995:155:1073-1080.
84. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy, N Engl J Med 1993:329:1456-1462.
85. Schunkert H, Hensc HW, Holmer SR, Slender M, Perz S, Keil U, Lorell BH, Ricgger GAJ: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy, N Engl J Med 1994;330:1634-1638.
86. Erdos EG: Angiotensin 1-converting enzyme and the changes in our concepts through the years, Hypertension 1990;16:363-370.
87. Pontremoli R, Bezantc GP, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bobola N, Ravazzoli R, Dc Ferrari G: Deletion polymorphism of the angiotensin I converting enzyme (ACE) gene is a risk factor for target organ damage (TOD) in essential hypertension (EH) (abstract), J Am Soc Nephrol 1995;6:647.
88. Marre M, Bemadct P, Gallois Y, Savagner F, Guvcne YY, Hallab M, Cambicn F, Passa P, Alhenc-Celas F: Relationships between angiotensin I converting enzyme, gene polymorphism, plasma levels, and diabetic retinal and renal complications, Diabetes 1994:43:384-388.
89. Tarnaow L, Cambien F, Rossing P, Nielsen P, Nielsen FS, Hansen BV, l., ecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-convcrting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients, Diabetes 1995:44: 489-494.
90. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995:47:1176-1181.
91. Doria A, Warrant JH, Krolcwski SA: Genetic predisposition to diabetic nephropathy, Evidence for a role of the angiotensin I-convcrting enzyme gene, Diabetes 1994:43:690-695.
92. Deckerl T, Feldt-Rasntussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage, The Steno hypothesis, Diabetologia 1989:32:219-226.
93. Parving HH, Gvntelbcrg F: Transcapillary escape rate of albumin and plasma volume in essential hypertension, Circ Res 1973:32:643-650.
94. Norgaard K, Jensen T, Feldt-Rasmusscn B: Transcapillary escape rate of albumin in hypertensive patients with type I (insulin-dependent) diabetes mellitus, Diabetologia 1993:36:57-61.
95. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmusscn B: Microalbuminuria reflects a generalized transvascular leakiness in clinically healthy subjects, Clin Sci 1995:88:629-633.
96. Hickey NC, Hudlicka O, Gosling P, Shearman CP, Simms MH: Intermittent claudication incites systemic neutrophil activation and increased vascular permeability, Br J Surg 1993;80:181-184.
97. Hickey NC, Gosling P, Baar S, Shearman CP, Simms MH: Effect of surgery on the systemic inflammatory response to intermittent claudication, Br j Surg 1990:77:1121-1124.
98. Gruden G, Bruno A, Estivi P, Ferrerò R, Pagano G, Cavallo-Perin P: Albumin excretion rate is not increased in atherosclerotic patients with vascular disease, Eur Rev Med Pharmacol Sci 1991:13:121-125.
99. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM: Inhibition of nitric oxide synthesis in forearm vasculature of insulin dependent diabetic patients: Blunted vasoconstriction in patients with microalbuminuria, Clin Sci 1993;85:687-693.
100. Jaffe EA, Nachman RL: Subunit structure of factor VIII antigen synthetized by cultured human endothelial cells, J Clin Invest 1975; 56:698-702.
101. Thompson SG, Kienast J, PykeSDM, Havcr-kate F, Van De Loo JCW: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, N Engl J Med 1995;332:635-641.
102. Stehouwer CDA, Nauta JJP, Zcldcnrust GC, Hacxkeng WHL, Donker AJM, Den Ottolander GJH: Urinary’ albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin dependent diabetes mellitus, Lancet 1992;340:319-323.
103. Dawnay A, McWilson AG, Lamb E, Kirby JDT, Cattel WR: Microalbuminuria in systemic sclerosis, Ann Rheum Dis 1992:51: 384-388.